Deposits of clastic carbonate-dominated (calciclastic) sedimentary slope systems in the rock record have been identified mostly as linearly-consistent carbonate apron deposits, even though most ancient clastic carbonate slope deposits fit the submarine fan systems better. Calciclastic submarine fans are consequently rarely described and are poorly understood. Subsequently, very little is known especially in mud-dominated calciclastic submarine fan systems. Presented in this study are a sedimentological core and petrographic characterisation of samples from eleven boreholes from the Lower Carboniferous of Bowland Basin (Northwest England) that reveals a >250 m thick calciturbidite complex deposited in a calciclastic submarine fan setting. Seven facies are recognised from core and thin section characterisation and are grouped into three carbonate turbidite sequences. They include: 1) Calciturbidites, comprising mostly of highto low-density, wavy-laminated bioclast-rich facies; 2) low-density densite mudstones which are characterised by planar laminated and unlaminated muddominated facies; and 3) Calcidebrites which are muddy or hyper-concentrated debrisflow deposits occurring as poorly-sorted, chaotic, mud-supported floatstones. These

Phd by thesis

In recent years, tools for the development of new drugs have been dramatically improved. These include genomic and proteomic research, numerous biophysical methods, combinatorial chemistry and screening technologies. In addition, early ADMET studies are employed in order to significantly reduce the failure rate in the development of drug candidates. As a consequence, the lead finding, lead optimization and development process has gained marked enhancement in speed and efficiency. In parallel to this development, major pharma companies are increasingly outsourcing many components of drug discovery research to biotech companies. All these measures are designed to address the need for a faster time to market. New screening methodologies have contributed significantly to the efficiency of the drug discovery process. The conventional screening of single compounds or compound libraries has been dramatically accelerated by high throughput screening methods. In addition, in silico screening methods allow the evaluation of virtual compounds. A wide range of new lead finding and lead optimization opportunities result from novel screening methods by NMR, which are the topic of this review article.

Drug Discovery Today

1,10-Phenanthroline: a versatile building block for the construction of ligands for various purposes

Dye-doped nanoparticles for bioanalysis

The advent of chemical tools for cellular imaging--from organic dyes to green fluorescent proteins--has revolutionized the fields of molecular biology and biochemistry. Lanthanide-based probes are a new player in this area, as the last decade has seen the emergence of the first responsive luminescent lanthanide probes specifically intended for imaging cellular processes. The potential of these probes is still undervalued by the scientific community. Indeed, this class of probes offers several advantages over organic dyes and fluorescent proteins. Their very long luminescence lifetimes enable quantitative spatial determination of the intracellular concentration of an analyte through time-gating measurements. Their emission bands are very narrow and do not overlap, enabling the simultaneous use of multiple lanthanide probes to quantitatively detect several analytes without cross-interference. Herein we describe the principles behind the development of this class of probes. Sensors for a desired analyte can be designed by rationally manipulating the parameters that influence the luminescence of lanthanide complexes. We will discuss sensors based on varying the number of inner-sphere water molecules, the distance separating the antenna from the lanthanide ion, the energies of excited states of the antenna, and PeT switches.

Principles of responsive lanthanide-based luminescent probes for cellular imaging.

Two attractive detection strategies for bioassays are reviewed in this article. Both approaches use the highly sensitive time-resolved luminescence detection of lanthanide complexes in combination with a signal amplification scheme. While enzyme-amplified lanthanide luminescence (EALL) has been an established technique for more than a decade, nanoparticles doped with luminescent lanthanide complexes have been introduced very recently. In this paper, the basic properties and major applications of both techniques are presented, and their future perspectives are discussed critically.

Detection strategies for bioassays based on luminescent lanthanide complexes and signal amplification

Screening of a small library of tripod ligands resulted in the discovery of bis(2-pyridylmethyl)-(2-hydroxybenzyl)amine (HL1) as a new sensitiser, which is able to transfer its excitation energy to terbium(III). After synthesis of the acetic acid ester of HL1, a highly selective method for the determination of porcine liver esterase by means of enzyme amplified lanthanide luminescence (EALL) was developed. Enzyme-catalysed cleavage of the ester results in the formation of HL1. After excitation at 297 nm, the characteristic emission of Tb(III) at 545 nm is observed and used to determine the esterase concentration. In contrast to existing EALL methods, this method may be carried out at neutral pH and without further additives. Limit of detection for porcine liver esterase is 10−9 mol l−1 and limit of quantification is 3 × 10−9 mol l−1. A linear calibration range of two decades starting at the limit of quantification is observed.

A tripod ligand as new sensitiser for the enzyme amplified lanthanide luminescence determination of esterase

Two complementary methods for reaction monitoring of the esterase-catalyzed cleavage of bis(2-pyridylmethyl)(2-acetoxyphenyl)amine are developed and compared. While enzyme-amplified lanthanide luminescence (EALL) allows for the time-resolved fluorescence determination of the intrinsically non-fluorescent product, both substrate and product of the enzymatic reaction may be determined simultaneously by electrospray mass spectrometry (ESI-MS). Excitation wavelength for the Tb(III) complex of the reaction product is 297 nm and emission was detected at 545 nm, which is the characteristic emission wavelength of the terbium(III) ion. In contrast to other EALL techniques, the presented method allows for the direct monitoring of an enzymatic conversion without any further sample preparation (e.g., rebuffering). For the mass spectrometric measurements the mass traces were set to m/z=306, 328, 348, and 370 for the protonated ester, the resulting phenol and their sodium adducts, respectively.

Reaction monitoring of enzyme-catalyzed ester cleavage by time-resolved fluorescence and electrospray mass spectrometry: method development and comparison

Tanja Steinkamp

Papers

Detection strategies for bioassays based on luminescent lanthanide complexes and signal amplification

A tripod ligand as new sensitiser for the enzyme amplified lanthanide luminescence determination of esterase

Reaction monitoring of enzyme-catalyzed ester cleavage by time-resolved fluorescence and electrospray mass spectrometry: method development and comparison

Detection scheme for bioassays based on 2,6-pyridinedicarboxylic acid derivatives and enzyme-amplified lanthanide luminescence

Lanthanide-induced hydrolysis of 4,7-diphenyl-1,10-phenanthroline-2,9-dicarboxylic acid esters